Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Regulating certain sex hormones may help delay facial aging.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Some supplements and hormones can increase hair loss by raising DHT levels.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Escin may help treat hair loss by boosting a specific cell growth pathway.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.